Anesthesia-intensive care department - Cochin - Port-Royal hospital - APHP
Paris, Île-de-France Region, 75014, France
NCT Number: NCT06361693
The aim of this research would be to determine the efficacy and effects of preoxygenation when performed by the patient (mask held by the patient).
This is the concept of "self-preoxygenation".
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Paris, Île-de-France Region, 75014, France
Pre-oxygenation is a fundamental element of the induction sequence in anesthesia, described and recommended since 1955. Numerous studies have examined and compared the various techniques for implementing this procedure in terms of duration, objectives, equipment, patient characteristics and conditions. None of them specifies who should hold the mask when carrying out this recommendation. In everyday practice, patients are often asked to hold the mask themselves. A preliminary survey showed that 86% of patients are offered this option. The professionals questioned cited relational reasons (83%) above all, but also organizational reasons (43%).
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Management is not modified. Routine monitoring (ECG, BP, SpO2). As in care, the patient takes the mask and the respirator is started, delivering an inspired oxygen fraction of 100% (FiO2=1).
Monitoring of : inspired fraction of oxygen, expired fraction of oxygen and end-tidal fraction of carbon dioxide. The ventilator also provides the respiratory rate and tidal volume carried out by the patient.
The fresh gas flow is set by default and will be adjusted to 12l/min for patient comfort.After less than a minute, a normal capnia curve and the presence of an FeO2 value appear. Here, time is standardized to 1 min. In the absence of one of these elements, the caregiver always takes control of preoxygenation.Timer is started, it is T0 min. At T 3min, collection of values and decision-making :
APAIS scale
Visual analog anxiety scale (VAS-A)
Visual analog comfort scale (VAS-C)
Time frame: 3 minuts after the beginning of auto-preoxygenation - Day 1
Percentage of patients achieving a FeO2>90% in 3 min at 12L/min fresh gas flow on 100% oxygen.
To Evaluate the efficacity of the self-preoxygenation Assessing the effectiveness of auto-preoxygenation
Time frame: At arrival in the Day Surgery Unit - Day 1
Percentage of patients with a total APAIS anxiety score greater than 10/20 in women, 12/20 in men on arrival in the operating room
Time frame: At arrival in the Day Surgery Unit - Day 1
Percentage of patients with a decrease in the visual analog anxiety scale score (VAS-A) between arrival and discharge in the Day Surgery Unit.
Assessing the effect of self-preoxygenation on preoperative anxiety
Time frame: At discharge from the Day Surgery Unit - Day 1
Percentage of patients with a decrease in the visual analog anxiety scale score (VAS-A) between arrival and discharge in the Day Surgery Unit.
Assessing the effect of self-preoxygenation on preoperative anxiety
Time frame: At discharge from the Day Surgery Unit - Day 1
Percentage of patients having obtained a visual analog comfort scale (VAS-C) score greater than 5 out of 10 upon discharge from the Day Surgery Unit.
Assessing the effect of self-preoxygenation on comfort
Assistance Publique - Hôpitaux de Paris
Other
"Observational Descriptive Study of Patient-performed Preoxygenation, the "Autopreoxygenation Concept""
Acronym: ApréOx
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07259629
Anesthesia, Glucose Metabolism Disorders
Exeter, Devon, United Kingdom
View Trial DetailsNCT03972423
Anesthesia, Anesthesia Complication
Versailles, IDF, France
View Trial DetailsNCT05111340
Aberrant Motor Behavior in Dementia, Anesthesia
Arras, France
View Trial DetailsNCT07647588
Anesthesia, Behavior
Elâzığ, Turkey (Türkiye)
View Trial Details